{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:31:35Z","timestamp":1791293495205,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.exphem.2009.09.009","type":"journal-article","created":{"date-parts":[[2009,10,7]],"date-time":"2009-10-07T08:17:01Z","timestamp":1254903421000},"page":"1411-1422","source":"Crossref","is-referenced-by-count":41,"title":["Polycythemia vera erythroid precursors exhibit increased proliferation and apoptosis resistance associated with abnormal RAS and PI3K pathway activation"],"prefix":"10.1016","volume":"37","author":[{"given":"Jacob P.","family":"Laubach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly H.","family":"Salter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Potti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat O.","family":"Arcasoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2009.09.009_bib1","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1056\/NEJM197406132902419","article-title":"Letter: Bone-marrow responses in polycythemia vera","volume":"290","author":"Prchal","year":"1974","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2009.09.009_bib2","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1182\/blood.V52.6.1196.1196","article-title":"Erythropoietin (Ep) dose-response curves for three classes of erythroid progenitors in normal human marrow and in patients with polycythemia vera","volume":"52","author":"Eaves","year":"1978","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2009.09.009_bib3","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1182\/blood.V59.2.447.447","article-title":"Erythroid progenitors in polycythemia vera: demonstration of their hypersensitivity to erythropoietin using serum free cultures","volume":"59","author":"Casadevall","year":"1982","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2009.09.009_bib4","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1172\/JCI114303","article-title":"Erythropoietin receptors in polycythemia vera","volume":"84","author":"Means","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2009.09.009_bib5","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/j.1365-2141.1994.tb05119.x","article-title":"Molecular analysis of the erythropoietin receptor system in patients with polycythaemia vera","volume":"88","author":"Hess","year":"1994","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2009.09.009_bib6","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nature03546","article-title":"A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera","volume":"434","author":"James","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2009.09.009_bib7","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ccr.2005.03.023","article-title":"Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis","volume":"7","author":"Levine","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2009.09.009_bib8","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1056\/NEJMoa051113","article-title":"A gain-of-function mutation of JAK2 in myeloproliferative disorders","volume":"352","author":"Kralovics","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2009.09.009_bib9","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(05)74230-6","article-title":"Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders","volume":"365","author":"Baxter","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.exphem.2009.09.009_bib10","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1182\/blood-2005-03-1320","article-title":"Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders","volume":"106","author":"Jones","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2009.09.009_bib11","doi-asserted-by":"crossref","first-page":"22788","DOI":"10.1074\/jbc.C500138200","article-title":"Identification of an acquired JAK2 mutation in polycythemia vera","volume":"280","author":"Zhao","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2009.09.009_bib12","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.1182\/blood-2005-12-4824","article-title":"Expression of Jak2V617F causes a polycythemia vera-like disease with associated myelofibrosis in a murine bone marrow transplant model","volume":"107","author":"Wernig","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2009.09.009_bib13","doi-asserted-by":"crossref","first-page":"11156","DOI":"10.1158\/0008-5472.CAN-06-2210","article-title":"Characterization of murine JAK2V617F-positive myeloproliferative disease","volume":"66","author":"Bumm","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2009.09.009_bib14","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1182\/blood-2006-02-002030","article-title":"JAK2V617F expression in murine hematopoietic cells leads to MPD mimicking human PV with secondary myelofibrosis","volume":"108","author":"Lacout","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2009.09.009_bib15","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1371\/journal.pone.0000018","article-title":"Molecular pathogenesis and therapy of polycythemia induced in mice by JAK2 V617F","volume":"1","author":"Zaleskas","year":"2006","journal-title":"PLoS ONE"},{"key":"10.1016\/j.exphem.2009.09.009_bib16","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1182\/blood-2007-08-107748","article-title":"Ratio of mutant JAK2-V617F to wild-type Jak2 determines the MPD phenotypes in transgenic mice","volume":"111","author":"Tiedt","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2009.09.009_bib17","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/sj.leu.2405043","article-title":"Development of ET, primary myelofibrosis and PV in mice expressing JAK2 V617F","volume":"22","author":"Shide","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2009.09.009_bib18","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1002\/cncr.22240","article-title":"JAK2 (V617F) as an acquired somatic mutation and a secondary genetic event associated with disease progression in familial myeloproliferative disorders","volume":"107","author":"Rumi","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.exphem.2009.09.009_bib19","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1182\/blood-2005-12-4852","article-title":"Genetic and clinical implications of the Val617Phe JAK2 mutation in 72 families with myeloproliferative disorders","volume":"108","author":"Bellanne-Chantelot","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2009.09.009_bib20","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.exphem.2006.11.012","article-title":"Polycythemia vera is not initiated by JAK2V617F mutation","volume":"35","author":"Nussenzveig","year":"2007","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2009.09.009_bib21","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1182\/blood-2005-11-009605","article-title":"Acquisition of the V617F mutation of JAK2 is a late genetic event in a subset of patients with myeloproliferative disorders","volume":"108","author":"Kralovics","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2009.09.009_bib22","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0092-8674(00)81167-8","article-title":"Jak2 is essential for signaling through a variety of cytokine receptors","volume":"93","author":"Parganas","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2009.09.009_bib23","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0092-8674(93)90414-L","article-title":"JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin","volume":"74","author":"Witthuhn","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2009.09.009_bib24","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1128\/MCB.17.5.2497","article-title":"Activation of Jak2 catalytic activity requires phosphorylation of Y1007 in the kinase activation loop","volume":"17","author":"Feng","year":"1997","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.exphem.2009.09.009_bib25","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.tcb.2005.01.007","article-title":"Turning cells red: signal transduction mediated by erythropoietin","volume":"15","author":"Richmond","year":"2005","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.exphem.2009.09.009_bib26","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/0092-8674(95)90351-8","article-title":"Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals","volume":"80","author":"Klingmuller","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2009.09.009_bib27","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1182\/blood.V86.1.15.bloodjournal86115","article-title":"Primary familial polycythemia: a frameshift mutation in the erythropoietin receptor gene and increased sensitivity of erythroid progenitors to erythropoietin","volume":"86","author":"Sokol","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2009.09.009_bib28","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0301-472X(98)00003-4","article-title":"A human erythropoietin receptor gene mutant causing familial erythrocytosis is associated with deregulation of the rates of Jak2 and Stat5 inactivation","volume":"27","author":"Arcasoy","year":"1999","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2009.09.009_bib29","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1182\/blood.V94.7.2530.419k35_2530_2532","article-title":"Erythropoietin receptor mutations associated with familial erythrocytosis cause hypersensitivity to erythropoietin in the heterozygous state","volume":"94","author":"Watowich","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2009.09.009_bib30","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0092-8674(00)81013-2","article-title":"Fetal anemia and apoptosis of red cell progenitors in Stat5a-\/-5b-\/- mice: a direct role for Stat5 in Bcl-X(L) induction","volume":"98","author":"Socolovsky","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2009.09.009_bib31","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1182\/blood.V98.12.3261","article-title":"Ineffective erythropoiesis in Stat5a(-\/-)5b(-\/-) mice due to decreased survival of early erythroblasts","volume":"98","author":"Socolovsky","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2009.09.009_bib32","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1182\/blood-2005-10-009514","article-title":"Constitutive activation of STAT5 and Bcl-xL overexpression can induce endogenous erythroid colony formation in human primary cells","volume":"108","author":"Garcon","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2009.09.009_bib33","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1182\/blood-2007-07-102848","article-title":"Stat5 activation enables erythropoiesis in the absence of EPOR and Jak2","volume":"111","author":"Grebien","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2009.09.009_bib34","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1182\/blood-2004-04-1362","article-title":"Constitutive activation of the MEK\/ERK pathway mediates all effects of oncogenic H-ras expression in primary erythroid progenitors","volume":"104","author":"Zhang","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2009.09.009_bib35","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1182\/blood-2005-02-0684","article-title":"Core erythropoietin receptor signals for late erythroblast development","volume":"107","author":"Menon","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2009.09.009_bib36","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1073\/pnas.94.7.3016","article-title":"Identification of a novel pathway important for proliferation and differentiation of primary erythroid progenitors","volume":"94","author":"Klingmuller","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2009.09.009_bib37","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1182\/blood-2005-06-2304","article-title":"AKT induces erythroid-cell maturation of JAK2-deficient fetal liver progenitor cells and is required for Epo regulation of erythroid-cell differentiation","volume":"107","author":"Ghaffari","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2009.09.009_bib38","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1365-2141.2005.05580.x","article-title":"Co-operative signalling mechanisms required for erythroid precursor expansion in response to erythropoietin and stem cell factor","volume":"130","author":"Arcasoy","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2009.09.009_bib39","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1182\/blood.V92.10.3658","article-title":"Growth and differentiation of human stem cell factor\/erythropoietin-dependent erythroid progenitor cells in vitro","volume":"92","author":"Panzenbock","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2009.09.009_bib40","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nature04296","article-title":"Oncogenic pathway signatures in human cancers as a guide to targeted therapies","volume":"439","author":"Bild","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2009.09.009_bib41","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1038\/nm1491","article-title":"Genomic signatures to guide the use of chemotherapeutics","volume":"12","author":"Potti","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.exphem.2009.09.009_bib42","doi-asserted-by":"crossref","first-page":"e1373","DOI":"10.1371\/journal.pone.0001373","article-title":"Age-specific differences in oncogenic pathway deregulation seen in human breast tumors","volume":"3","author":"Anders","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.exphem.2009.09.009_bib43","first-page":"311","article-title":"In vitro sensitivity of human erythroid progenitors to hemopoietic growth factors: studies on primary and secondary polycythemia","volume":"79","author":"Montagna","year":"1994","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2009.09.009_bib44","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1182\/blood-2006-10-054940","article-title":"The JAK2 617V > F mutation triggers erythropoietin hypersensitivity and terminal erythroid amplification in primary cells from patients with polycythemia vera","volume":"110","author":"Dupont","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2009.09.009_bib45","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1182\/blood.V98.5.1374","article-title":"Growth factor withdrawal from primary human erythroid progenitors induces apoptosis through a pathway involving glycogen synthase kinase-3 and Bax","volume":"98","author":"Somervaille","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2009.09.009_bib46","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.exphem.2006.12.007","article-title":"In vitro expansion of erythroid progenitors from polycythemia vera patients leads to decrease in JAK2 V617F allele","volume":"35","author":"Gaikwad","year":"2007","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2009.09.009_bib47","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1182\/blood-2005-07-3037","article-title":"Increased death receptor resistance and FLIPshort expression in polycythemia vera erythroid precursor cells","volume":"107","author":"Zeuner","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2009.09.009_bib48","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1741-7007-2-7","article-title":"PI3 kinase is important for Ras, MEK and Erk activation of Epo-stimulated human erythroid progenitors","volume":"2","author":"Schmidt","year":"2004","journal-title":"BMC Biol"},{"key":"10.1016\/j.exphem.2009.09.009_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yexcr.2005.04.030","article-title":"Erythropoietin receptor Y479 couples to ERK1\/2 activation via recruitment of phospholipase Cgamma","volume":"309","author":"Halupa","year":"2005","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.exphem.2009.09.009_bib50","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1158\/1078-0432.CCR-07-0524","article-title":"WP1066, a novel JAK2 inhibitor, suppresses proliferation and induces apoptosis in erythroid human cells carrying the JAK2 V617F mutation","volume":"14","author":"Verstovsek","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.exphem.2009.09.009_bib51","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.exphem.2004.10.017","article-title":"Increased erythropoiesis in polycythemia vera is associated with increased erythroid progenitor proliferation and increased phosphorylation of Akt\/PKB","volume":"33","author":"Dai","year":"2005","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2009.09.009_bib52","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJM199802263380902","article-title":"Expression of Bcl-x in erythroid precursors from patients with polycythemia vera","volume":"338","author":"Silva","year":"1998","journal-title":"N Engl J Med"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X09003890?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X09003890?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T21:07:51Z","timestamp":1590181671000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X09003890"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":52,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S0301472X09003890"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2009.09.009","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}